Isospec Analytics launches its breakthrough biomolecular analysis technology that identifies unknown molecules at scale for pharmaceutical, agritech and nutrition companies. Lausanne, Switzerland When developing new drugs, nutitional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, […]
WATERTOWN, Mass. — Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire”) has announced that it has closed a $2.0 million private placement with True Remainders Ltd. for the sale and issuance of (i) an aggregate of 1,538,461 shares of Spectaire common stock, and (ii) an accompanying warrant to purchase up to 1,538,461 shares of Spectaire common stock […]
Proceeds support continued development and commercialization of cell engineering platform technology across research and clinical applications. Over 20 active partners to date, ranging from large pharmaceutical and biotechnology companies to leading academic institutions. CAMBRIDGE, Mass. — Today, Portal Biotechnologies, Inc. (“Portal”), a cell engineering platform company, announced a $5M pre-seed round led by Pear VC, […]
Proceeds to launch new RNA sequencing products, expand production capacity, develop new technologies and open US subsidiary. LAUSANNE, Switzerland — Alithea Genomics, an emerging leader in the field of large-scale RNA sequencing and transcriptomics, announced today the closing of a CHF 2.8 million ($3.2 million) extension to its seed financing. The round was led by the Novalis […]
Company to Provide Broader Access to its AI-Driven Cell-Free Protein Production Platform SAN LEANDRO, Calif. — Tierra Biosciences, the company behind the world’s first platform for predictive AI-guided cell-free technology enabling high-throughput on-demand custom protein synthesis, announced today that it closed an $11.4M Series A round. The investment was led by Material Impact with participation from new […]
Cambridge, Mass. – Vizgen, Inc., the life science company dedicated to improving human health by visualizing single-cell spatial genomics information, has announced a significant capital raise to fuel its continued growth and execution of long-term vision. At the same time, the company has also taken steps to streamline its operations and reduce headcount. These measures […]
CryoCloud, a dutch biotech startup that developed a proprietary data analysis platform, closed a pre-seed round at 500k Euros Their cloud-based cryoEM data analysis platform enables the fast and scalable determination of 3D protein structures used for drug discovery CryoCloud will use the funding to expand the capabilities of its platform to better support scientists […]
Financing led by Sands Capital brings total capital raised to nearly $250 million. Fremont, CA, US – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the first close of $100 million in Series C financing with the second close of an additional $28 million expected to happen within […]
Funding through Government of Canada’s Regional Quantum Initiative supports product development and commercialization efforts WATERLOO, ON – High Q Technologies Inc., an innovative life sciences company that develops quantum-enabled scientific instruments for protein characterization in drug discovery, announces a $3.75-million Government of Canada investment, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), as part of the Regional Quantum Initiative. The funding will support […]
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patients. Investment led by Mercia Ventures, with Calculus Capital and Angel investors also participating. BEDFORDSHIRE, England–MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate the development and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
